ReviewFrontiers in immunology2026

Targeting lineage-specific heterogeneity and hypovascular-fibrotic barriers may enable precision immunotherapy in pituitary neuroendocrine tumors.

Jiayu Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.